These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17042086)

  • 21. Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia: predicting factors for response.
    Sinsalo M; Aittoniemi J; Käyhty H; Vilpo J
    Leuk Lymphoma; 2002 Oct; 43(10):1967-9. PubMed ID: 12481893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemophilus influenzae type b. Epidemiology of invasive diseases, antimicrobial resistance of clinical isolates, and response to a conjugate vaccine in selected risk groups.
    Kristensen K
    Dan Med Bull; 1999 Sep; 46(4):303-12. PubMed ID: 10514939
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunization with Haemophilus influenzae (Hib) conjugate vaccine following discharge from hospital.
    Olowokure B; Spencer NJ; Hawker JI; Blair I
    Infection; 2003 Oct; 31(5):324-6. PubMed ID: 14556057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Globalisation of Hib vaccination--how far are we?
    Andrade AL; Martelli CM
    Lancet; 2005 Jan 1-7; 365(9453):5-7. PubMed ID: 15639660
    [No Abstract]   [Full Text] [Related]  

  • 28. [Increase in the number of invasive Haemophilus influenzae type b infections].
    Spanjaard L; van den Hof S; de Melker HE; Vermeer-de Bondt PE; van der Ende A; Rijkers GT
    Ned Tijdschr Geneeskd; 2005 Dec; 149(49):2738-42. PubMed ID: 16375019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
    Scheifele DW; Bettinger JA; Halperin SA; Law B; Bortolussi R
    Pediatr Infect Dis J; 2008 Aug; 27(8):755-7. PubMed ID: 18594482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hib vaccination: recent paper from Finland suggests that a prolonged three dose schedule offers effective protection against disease.
    European Union Invasive Bacterial Infection Surveillance scheme
    Euro Surveill; 2005 Jan; 10(1):E050113.1. PubMed ID: 16556943
    [No Abstract]   [Full Text] [Related]  

  • 31. Bacteria, polysaccharides, vaccines and boosting: measuring and maintaining population immunity.
    Goldblatt D
    Arch Dis Child; 2008 Aug; 93(8):646-7. PubMed ID: 18644932
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of oropharyngeal colonization by Haemophilus influenzae type b in Iranian children.
    Karimi A; Alborzi A; Fahimzad A; Gooya M; Esteghamati A; Armin SH; Fallah F
    East Mediterr Health J; 2009; 15(3):544-8. PubMed ID: 19731770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Good effect of general HIB vaccination of children].
    Garpenholt O; Silfverdal SA; Hugosson S; Fredlund H; Olcén P
    Lakartidningen; 1997 Jan; 94(3):113. PubMed ID: 9053621
    [No Abstract]   [Full Text] [Related]  

  • 34. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.
    Hajjeh RA; Privor-Dumm L; Edmond K; O'Loughlin R; Shetty S; Griffiths UK; Bear AP; Cohen AL; Chandran A; Schuchat A; Mulholland EK; Santosham M
    Vaccine; 2010 Oct; 28(43):7123-9. PubMed ID: 20659515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycoconjugate vaccines against Haemophilus influenzae type b.
    Fernandez Santana V; Peña Icart L; Beurret M; Costa L; Verez Bencomo V
    Methods Enzymol; 2006; 415():153-63. PubMed ID: 17116473
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa.
    Gessner BD
    Expert Rev Vaccines; 2009 Jan; 8(1):91-102. PubMed ID: 19093776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failures after immunization with Haemophilus influenzae type b vaccines--1991-1995.
    Scheifele D; Gold R; Marchessault V; Duclos P
    Can Commun Dis Rep; 1996 Feb; 22(3):17-20, 23. PubMed ID: 8822260
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of the influence of the bacterial vaccines Pneumo-23 and Act-HIB on the course of the chronic inflammatory process of the respiratory organs in children].
    Ryzhov AA; Katosova LK; Kostinov MP; Volkov IK; Magarshak OO
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):84-7. PubMed ID: 16028524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record.
    World Health Organization
    Wkly Epidemiol Rec; 2006 Nov; 81(47):445-52. PubMed ID: 17124755
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of nontypeable Haemophilus influenzae protein E (PE) as a microbial adjuvant on the amount of antibody against PRP of Haemophilus influenzae type b (Hib) in BALB/c mice.
    Tavakoli M; Bouzari S; Jafari A; Oloomi M; Asadi Karam MR; Najar-Peerayeh S; Siadat SD
    Microb Pathog; 2019 Apr; 129():78-81. PubMed ID: 30682526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.